–
–
The vaccine against COVID-19 of “Pfizer” / “Bayontek” PHOTO: Pixay
–
The vaccine against the Omicron variant of the new coronavirus, developed by Pfizer, will be ready in March, CEO Albert Burla said in an interview with CNBC.
He explained that the production of doses of the drug has already begun, although it is risky. Burla also said that the vaccine will be effective against other known variants of Kovid-19, BTA reported.
According to him, it is not yet clear whether there is a need for a drug adapted specifically for Omicron, but Pfizer will prepare a certain amount of doses in advance due to inquiries from countries.
“We hope that we can achieve something more effective in terms of protection against infections, as the prevention of hospitalization and severe illness that current drugs provide is at an acceptable level, but provided, for example, that a third dose is given.” , explained the executive director of Pfizer.
In December, Dr. Anthony Fauci, the chief infectious disease expert in the United States, said there was no need for a Omicron-specific drug because the booster doses currently in use “work great.”
The head of the company “Modern” Stefan Bansel told CNB earlier today that their preparation, adapted for the Omicron variant, will be ready in the fall.
– .
